A Conserved Domain in Axonal Targeting of Kv1 (Shaker) VoltageGated Potassium Channels
Chen Gu, Yuh Nung Jan, Lily Yeh Jan * Axonal voltage-gated potassium (Kv1) channels regulate action-potential invasion and hence transmitter release. Although evolutionarily conserved, what mediates their axonal targeting is not known. We found that Kv1 axonal targeting required its T1 tetramerization domain. When fused to unpolarized CD4 or dendritic transferrin receptor, T1 promoted their axonal surface expression. Moreover, T1 mutations eliminating Kv␤ association compromised axonal targeting, but not surface expression, of CD4-T1 fusion proteins. Thus, proper association of Kv␤ with the Kv1 T1 domain is essential for axonal targeting.
Axonal potassium channels in vertebrates and invertebrates control the fidelity of actionpotential propagation, especially at sites having a low safety factor such as axonal branch points, varicosities, and nerve terminals (1) (2) (3) (4) . Transmitter modulation of these channels regulates synaptic efficacy by altering the likelihood of action-potential invasion (5) . In the mammalian nervous system, voltage-gated potassium channels in the Kv1 (Shaker) family also reside in axons (6) ; loss of their channel function results in behavioral abnormalities (7, 8) and symptoms such as limbshaking in patients with episodic ataxia (9) . Notwithstanding their long history as the first potassium channel discovered (1) and cloned (10), Kv1 axonal targeting signal remains a mystery. Manipulations blocking channel appearance in axons prevent channel surface expression (11) , which compounds analyses because of their impact on the channel exit from the endoplasmic reticulum (ER) (12) . Studies of chimeras of Kv1.4 and Kv4.2 identify a C-terminal dileucine motif important for Kv4 dendritic targeting, but not the axonal targeting signal for Kv1 (13) .
Cultured hippocampal neurons preserve polarized Kv channel expressions as in vivo and thus provide a good assay for axonal targeting (14) . Endogenous Kv1.2 and Kv4.2 exhibited largely nonoverlapping distributions in distal neuronal processes after 21 days in vitro (DIV) (Fig. 1A ). Kv4.2 was restricted to microtubule-associated protein type 2 (MAP2)-positive dendrites and concentrated on or near the dendritic surface ( Fig. 1C and fig. S1A pressed in intracellular compartments in dendrites (Fig. 1B and fig. S1 , B and C).
To monitor surface expression of Kv1.2, we transfected hippocampal neurons at 7 DIV, shortly before endogenous Kv1.2 appears, with Kv1.2 carrying an extracellular hemagglutinin (HA) tag, and examined its expression 2 to 3 days later. Like other axonal membrane proteins (14) , HA-tagged Kv1.2 resided in dendrites and axons, but its surface expression was primarily axonal (Fig. 2A) .
By quantifying the polarized surface expression ( fig. S2) , we determined the axonal polarity index (API), the ratio of average fluorescence intensity for major axonal versus dendritic branches, to be 3.2 Ϯ 0.4 (n ϭ 16) for HA-tagged Kv1.2, and 3.6 Ϯ 0.3 (n ϭ 15) for HA-tagged Kv1.2 fused to green fluorescence protein (GFP) at its N-terminus (Fig.  2C and fig. S3 ).
To search for Kv1 axonal targeting signal, we first mutated the conserved C-terminal PDZ-binding motif. The V499A mutation (in which Val 499 is replaced by Ala) reduced surface expression ( fig. S4A ) but not axonal targeting (API for GFP-Kv1.2HA-V499A: 2.8 Ϯ 0.5, n ϭ 11) (15). We also fused the IRK1 (Kir2.1) forward trafficking signals (16) to the Kv1.2 C-terminus, to disrupt the PDZ binding motif without compromising surface expression, which revealed robust axonal targeting (API for Kv1.2HA-FCYENE: 4.0 Ϯ 0.5, n ϭ 10). Thus, the PDZ binding motif is important for surface expression but not axonal targeting of Kv1.2.
Some axonal membrane proteins achieve their polarized distribution via preferential endocytosis from dendritic membranes (14) . We tested this possibility by mutating three potential tyrosine-based endocytic motifs (YXX⌽) (15) of Kv1.2. To our surprise, instead of reducing API, when Tyr is replaced by Ala, the Y458A mutation further increased it as compared with the wild type (API: (Fig. 2B and fig. S4 , B to D). As expected for an endocytic signal, Y458A tripled channel surface expression without affecting total protein level in COS-7 cells (fig.  S4A ). This tyrosine is important for both muscarinic cholinergic modulation and channel interaction with the dynamin-and actinbinding protein cortactin (17) , which raises the intriguing possibility of transmitter modulation of axonal Kv1.2 channel density.
We then tested whether the highly conserved Kv1 N-terminus could mediate axonal targeting. Deleting the first 30 amino acids had no effect (API: 3.3 Ϯ 0.5, n ϭ 15), but removing the first 150 amino acids including the T1 tetramerization domain (18) abolished both axonal targeting and surface expression ( fig. S5, n ϭ 10) . Circumventing T1's requirement for channel folding and assembly (19, 20) by replacing T1 with the GCN4-L1 coiled-coil tetramerization domain to restore surface expression (21), we found the channels without T1 only on the somatodendritic surface (API: 0, n ϭ 10) (Fig. 2C) . Thus, T1 is necessary for Kv1.2 axonal targeting.
To test whether the C-terminal domain acted in concert with T1 in axonal targeting, we examined C-terminal truncation mutants. However, removal of amino acids 430 to 499 abolished surface expression. Therefore, we fused either the N-or the C-terminal domain of Kv1 to CD4, which normally exhibits equal distribution on axonal and dendritic surfaces (Fig. 3A) , to see whether these domains could confer axonal targeting. Fusion of the C-terminal domain of Kv1.1, Kv1.2, or Kv1.4 to the cytoplasmic C-terminus of CD4 did not enhance axonal surface expression (Fig. 3C and fig. S6A ). By contrast, fusion of the Kv1.2 N-terminal domain including T1, but not fusion of either half of T1, tripled the axonal polarity index (Fig. 3, B and C, and  fig. S6B ) and thus revealed that T1 could promote CD4 axonal targeting.
To test whether T1 from Kv1 channels confers axonal targeting to the dendritic transferrin receptor (TfR), we fused T1 from Kv1.1, Kv1.2, or Kv1.4 to the cytoplasmic N-terminus of TfR and also a GFP tag to its extracellular C-terminus. The GFP-tagged TfR was restricted to the somatodendritic surface (22) . Remarkably, fusion of T1 from Kv1.2 or other Kv1 family members, but not from Kv4.2, caused TfR to appear on the axonal surface ( Fig. 3D and fig. S7 ).
To search for clues to the mechanism underlying T1-mediated axonal targeting, we relied on the crystal structure of Kv1.2 T1 tetramer (21) and mutated residues on the "top" or "sides" of T1 tetramer (Fig. 4,  A and B) . We predicted that mutations of residues "pointing out" (white side chains in Fig. 4, A and B) would disrupt T1 interaction with cellular targeting machinery. However, these five mutations had no effect on axonal targeting of CD4-T1 fusion proteins, neither did mutation of a putative phosphorylation site ( Y132F) at the end of T1 (Fig. 4C) . We then tested T1 mutations designed to disrupt interaction with Kv␤ (23) and found that these mutations (F69V, F69V/D70A, L72W) compromised axonal targeting (Fig. 4C) . We further examined five mutations at the interface between T1 monomers (E45K, T46V, and Y90A/Y91A on side A; S40W and R82D on side B), and found these mutations also impaired axonal targeting (Fig. 4C) . A majority of these mutations (green side chains in Fig. 4 , A and B) may have prevented Kv1.2 channel maturation and/or surface expression. However, they did not affect surface expression of CD4-T1. The use of the CD4 reporter thus enabled us to circumvent the difficulty in dissociating the requirement of T1 (and Kv␤) for ER export of Kv1 channels (12, 16, 19, 20) from their possible involvement in axonal targeting.
Given that all three mutations at T1-Kv␤ interface greatly reduced axonal targeting, we tested CD4-T1 association with Kv␤ and found all T1 mutations that still targeted CD4 to axons were associated with Kv␤2 coexpressed in HEK 293 cells (Fig. 4D) . Remarkably, in addition to mutations of the T1-Kv␤ interface, the two mutations on side B of the T1-T1 interface and even the T46V mutation on side A that stabilizes T1 tetramer (Fig. 4) . The other two mutations on side A (E45K and Y90A/Y91A) still associated with Kv␤2. Thus, simply having Kv␤ bound to CD4-T1 was not sufficient; rather, proper organization of T1 and Kv␤ was important for axonal targeting. Transfected GFP-Kv␤2 showed prominent axonal targeting ( fig. S8 ). In the mammalian brain, Kv1 channels are associated with SNARE proteins (the receptors for soluble NSF attachment proteins), probably because of direct interaction between Kv␤ and syntaxin 1A (24) . Our study thus lays the groundwork for future analyses of the cellular machinery for Kv1 axonal targeting and channel density regulation. Reelin is an extracellular protein that is crucial for layer formation in the embryonic brain. Here, we demonstrate that Reelin functions postnatally to regulate the development of the neuromuscular junction. Reelin is required for motor end-plate maturation and proper nerve-muscle connectivity, and it directly promotes synapse elimination. Unlike layer formation, neuromuscular junction development requires a function of Reelin that is not mediated by Disabled1 or very-low-density lipoprotein receptors and apolipoprotein E receptor 2 receptors but by a distinct mechanism involving its protease activity.
Reelin (Reln) is encoded by the gene that is disrupted in reeler mice (1, 2) . These mutant mice display ataxia, tremors, and disruption of cortical structures. Reln function in corticogenesis is mediated by the adapter protein Dis abled1 (Dab1) (3) (4) (5) , and by the very-lowdensity lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (ApoER2), two highaffinity Reln receptors (6) (7) (8) . Reln also possesses a serine protease activity (9) , but its function
is not yet known. After neuronal migration is complete, Reln continues to be expressed in areas of the brain where synapse remodeling takes place. Here, we investigated the possible role of Reln in synaptogenesis by analyzing the developing skeletal neuromuscular junction (NMJ). In rodents, NMJs develop postnatally (10) . Neuronal activity is important for maturation, in particular for the elimination of axonal terminals providing multiple innervation to the end plates. However, the molecular events that control this phenomenon are poorly understood. We found that motor neurons express Reln in the postnatal spinal cord. In situ hybridization of lumbar spinal cord sections with an antisense probe revealed expression of reln RNA in many spinal cord cells, including large cells located in the ventral horn (Fig. 1A) . No signal was detected with a sense probe (Fig. 1B) . Similar sections incubated with antibodies against the choline acetyltransferase (ChAT) marker confirmed Reln expression in somatic motor neurons (Fig. 1C and fig. S1 ). To study whether Reln is transported along motor axons, we processed soleus muscle sections of wild-type (Fig. 1D) or reeler mice (Fig.  1E) with antibodies against the neurofilament (NF) 200 nerve marker. A strong Reln expression was observed in and around the nerve bundle of normal mice. A faint signal was observed along muscle fibers, suggesting that they may also produce Reln. Confocal analysis of NMJs labeled with antibodies against the presynaptic marker ␤-synuclein (Syn) indicated that Reln is concentrated at the synapse and that the two proteins precisely colocalized (Fig. 1, F to I) . Thus, motor axons express Reln, transport it to the NMJ, and contribute to its expression in the muscle. Incomplete overlap with the Schwann cell marker S-100 suggested that these cells do not express Reln ( fig. S1 ). Reln secretion is essential for its activity (11, 12) . In nonpermeabilized muscle tissue the extracellular Reln signal was weak ( fig. S1 ) but detectable at high magnification. The presence of a signal that overlapped motor end plates stained with tetramethyl rhodamine isothiocyanate (TRITC)-␣-bungarotoxin (BTX) suggested that Reln is indeed secreted at the NMJ (Fig.  1, J to L) .
Because in the embryonic brain Reln regulates layer formation through Dab1 and the VLDLR and ApoER2 receptors, we analyzed the expression of these proteins in the motor system. We found no Dab1 signal in the postnatal spinal cord ( fig. S2 ) or motor axons, but this protein was present at the NMJ (Fig.  2A) . The absence of signal in Dab1-mutant sections demonstrates the specificity of the
